Aurobindo Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has informed the stock exchanges that its trading window will be closed starting April 1, 2026, in line with SEBI's Insider Trading Regulations. The closure applies to all designated persons, including promoters, directors, key managerial personnel, employees, connected persons, and their immediate relatives. The window will reopen 48 hours after the company declares its audited financial results for the financial year ending March 31, 2026. The date of the board meeting to approve these annual results will be announced later. This is a routine compliance filing and not an indication of any specific corporate action.
This is a standard regulatory filing with no direct impact on the stock price. It signals that the company's FY26 audited results are forthcoming, and insiders are barred from trading during the blackout period to prevent any unfair trading advantages.